Press Releases

12/31/2008
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain

12/15/2008
Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET

12/12/2008
Labopharm Comments on Recent Trading Activity

11/24/2008
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder

11/24/2008
Labopharm's NDA for Novel Trazodone Formulation accepted for review by FDA

11/7/2008
Labopharm Reports Results for Third Quarter Fiscal 2008

11/7/2008
Labopharm announces change to Board of Directors

10/29/2008
Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET)

9/22/2008
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression

9/16/2008
Labopharm to present at CIBC World Markets 7th Annual Eastern Institutional Investor Conference

8/11/2008
Labopharm to present at Canaccord Adams 28th Annual Global Growth Conference

8/8/2008
Labopharm reports results for second quarter fiscal 2008

7/31/2008
Labopharm's Once-Daily Tramadol Product Launched in South Korea, Australia, Romania and Austria

7/25/2008
Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET)

7/17/2008
FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response

7/7/2008
Labopharm Reacquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product

7/2/2008
Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol

6/30/2008
Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product

5/8/2008
Labopharm Reports Results for First Quarter Fiscal 2008

5/1/2008
Labopharm announces details for first quarter results conference call and annual meeting

4/28/2008
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer

4/1/2008
Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy

3/10/2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen

2/21/2008
Labopharm reports results for year end and fourth quarter fiscal 2007

2/13/2008
Labopharm's Once-Daily Tramadol Approved in South Korea and Australia

2/12/2008
Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)

2/8/2008
Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone

2/1/2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly

1/24/2008
Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova

1/24/2008
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol